Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Nautilus Biotechnology Inc (NAUT)
Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 340,267
  • Shares Outstanding, K 125,098
  • Annual Sales, $ 0 K
  • Annual Income, $ -57,920 K
  • 60-Month Beta 1.17
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.27
Trade NAUT with:

Options Overview Details

View History
  • Implied Volatility 73.00% ( -86.09%)
  • Historical Volatility 60.50%
  • IV Percentile 19%
  • IV Rank 15.93%
  • IV High 329.83% on 09/29/23
  • IV Low 24.32% on 05/16/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 16
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 503
  • Open Int (30-Day) 573

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 2
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.56 +6.25%
on 02/05/24
3.10 -12.26%
on 02/15/24
-0.16 (-5.56%)
since 02/01/24
3-Month
2.56 +6.25%
on 02/05/24
3.45 -21.27%
on 12/27/23
-0.21 (-7.17%)
since 12/01/23
52-Week
2.00 +36.00%
on 03/13/23
4.65 -41.51%
on 06/21/23
+0.57 (+26.51%)
since 03/01/23

Most Recent Stories

More News
Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

SEATTLE, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

NAUT : 2.72 (+1.12%)
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

NAUT : 2.72 (+1.12%)
Nautilus Biotechnology Reports First Quarter 2022 Financial Results

SEATTLE, May 03, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

NAUT : 2.72 (+1.12%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

RDBX and AMPE are leading our lists this morning

NFLX : 619.34 (+2.72%)
EE : 15.58 (-0.76%)
NAUT : 2.72 (+1.12%)
RDBX : 1.6500 (-52.86%)
MULN : 7.02 (-1.40%)
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

NAUT : 2.72 (+1.12%)
Nautilus Biotechnology to Present at EuPA and AACR Meetings

• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate...

NAUT : 2.72 (+1.12%)
Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors

Schrödinger President of R&D, Therapeutics brings extensive leadership in commercializing breakthrough biotechnologies to company developing platform for...

NAUT : 2.72 (+1.12%)
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results

SEATTLE, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome...

NAUT : 2.72 (+1.12%)
Nautilus to Participate in the 42nd Annual Cowen Health Care Conference

SEATTLE, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

NAUT : 2.72 (+1.12%)
Macellum Nominates Ten Highly Qualified and Independent Candidates for Election to the Kohl’s Board of Directors

Macellum Advisors GP, LLC (together with its affiliates, “Macellum” or “we”), a long-term holder of nearly 5% of the outstanding common shares of Kohl’s Corporation (NYSE: KSS) (“Kohl’s”...

KSS : 27.74 (-0.47%)
DISH : 5.77 (+1.94%)
CTO : 17.20 (+0.88%)
ALCO : 27.77 (+0.22%)
PVH : 137.84 (+0.86%)
GES : 25.34 (-0.16%)
NAUT : 2.72 (+1.12%)
BBWI : 45.68 (-0.04%)
VSCO : 28.44 (-0.42%)
EXPR : 2.66 (-3.27%)
M : 18.01 (+3.27%)
RILY : 16.84 (-8.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.

See More

Key Turning Points

3rd Resistance Point 3.00
2nd Resistance Point 2.89
1st Resistance Point 2.81
Last Price 2.72
1st Support Level 2.62
2nd Support Level 2.51
3rd Support Level 2.43

See More

52-Week High 4.65
Fibonacci 61.8% 3.64
Fibonacci 50% 3.33
Fibonacci 38.2% 3.01
Last Price 2.72
52-Week Low 2.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar